Core Viewpoint - 医渡科技 is actively repurchasing its shares, indicating confidence in its market position and future growth potential [1] Group 1: Share Buyback Activity - On October 22, 医渡科技 repurchased 17,700 shares for a total of 100,000 HKD [1] - Since September 26, the company has completed 8 share buybacks, with a total expenditure exceeding 20.4 million HKD [1] Group 2: Southbound Capital Inflows - On October 17, southbound funds net purchased 4.035 million shares of 医渡科技, accounting for 28.56% of the day's trading volume [1] - The net purchase amount by southbound funds on that day was approximately 22.88 million HKD, marking six consecutive days of net buying, with a cumulative total of 100 million HKD [1] Group 3: Product Development and Implementation - 医渡科技 recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a comprehensive process from intelligent medical record generation to patient education and smart nursing [1] - The self-developed "医渡大模型" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]

Group 1 - Company has been actively repurchasing shares, with a recent buyback on October 21 amounting to 340,000 HKD for nearly 60,000 shares [1] - Since September 26, the company has completed 7 buybacks, totaling over 20.3 million HKD [1] - As of October 21, the company's stock price closed at 5.69 HKD, reflecting a 1.07% increase [1] Group 2 - The company recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a full process from intelligent medical record generation to patient education and smart care [1] - The self-developed "Yidu Big Model" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]

Group 1 - Company has been actively repurchasing shares, with a recent buyback on October 21 amounting to 340,000 HKD for nearly 60,000 shares [1] - Since September 26, the company has completed 7 buybacks, totaling over 20.3 million HKD [1] - As of October 21, the company's stock price closed at 5.69 HKD, reflecting a 1.07% increase [1] Group 2 - The company recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a full process from intelligent medical record generation to patient education and smart care [1] - The self-developed "Yidu Big Model" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]